In vitro protein adsorption studies on nevirapine nanosuspensions for HIV/AIDS chemotherapy.

UNLABELLED Nevirapine is a poorly water-soluble antiretroviral drug. Intravenous nevirapine nanosuspensions (NS) (457 ± 10 nm) were prepared by high-pressure homogenization. NS were surface modified by stabilizer adsorption, e.g., serum albumin, polysaccharide and polyethylene glycol (PEG) 1000. The NS were characterized for mean particle size, particle size distribution and polydispersity index. The targeting potential of the nonmodified and three surface-modified NS to the mononuclear phagocytic system (MPS) cells that serve as potent viral reservoirs was assessed by in vitro protein adsorption studies using two-dimensional polyacrylamide gel electrophoresis (2-D PAGE). The adsorption patterns were qualitatively identical, but showed quantitative differences. The relatively adsorbed high amounts of immunoglobulins indicate uptake by liver and spleen, observed quantitative differences (e.g., the amount of dysopsonin albumin and apolipoproteins) can modulate the organ distribution. Controlled in vitro optimization of the protein adsorption by surface modification of the nanocrystals can reduce the number of animals required for in vivo studies and accelerate development of targeted nanoparticles. FROM THE CLINICAL EDITOR In this study, intravenous nevirapine (a poorly water-soluble antiretroviral drug) nanosuspensions were prepared by high-pressure homogenization and characterized.

[1]  D. Hochstrasser,et al.  Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface‐modified latex particles evaluated by two‐dimensional polyacrylamide gel electrophoresis , 1993, Electrophoresis.

[2]  R. Müller,et al.  Analysis of plasma protein adsorption onto polystyrene particles by two‐dimensional electrophoresis: Comparison of sample application and isoelectric focusing techniques , 2000, Electrophoresis.

[3]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[4]  J. Brash,et al.  Modification of liposomes with N-substituted polyacrylamides: identification of proteins adsorbed from plasma. , 1999, Biochimica et biophysica acta.

[5]  Future strategies for drug delivery with particulate systems , 1998 .

[6]  M. Sefton,et al.  Immunoblot analysis of proteins associated with HEMA-MMA microcapsules: human serum proteins in vitro and rat proteins following implantation. , 1998, Biomaterials.

[7]  Robert Gurny,et al.  Bioadhesion: Possibilities and Future Trends , 1990 .

[8]  P. Couvreur,et al.  Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting , 1999 .

[9]  L. Jorgensen,et al.  Protein adsorption and displacement at lipid layers determined by total internal reflection fluorescence (TIRF) , 2009, Journal of liposome research.

[10]  R. Müller,et al.  Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles. , 2003, Journal of drug targeting.

[11]  W. Semmler,et al.  Determination of Plasma Protein Adsorption on Magnetic Iron Oxides: Sample Preparation , 1997, Pharmaceutical Research.

[12]  V. Torchilin,et al.  "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. , 2006, Bioconjugate chemistry.

[13]  R. Müller,et al.  Interactions of nanoparticles with body proteins--improvement of 2D-PAGE-analysis by internal standard. , 2000, International journal of pharmaceutics.

[14]  R. Alyautdin,et al.  Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticles , 1997 .

[15]  R. Müller,et al.  The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908. , 1987, Life sciences.

[16]  J. van Lierop,et al.  Tuning the exchange bias in NiFe/Fe-oxide bilayers by way of different Fe-oxide based mixtures made with an ion-beam deposition technique. , 2007, Journal of nanoscience and nanotechnology.

[17]  K. Higaki,et al.  Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[19]  K. Higaki,et al.  Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers. , 2008, International journal of pharmaceutics.

[20]  R. Müller,et al.  Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[21]  Patrick Couvreur,et al.  Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis. , 2007, Biomacromolecules.

[22]  J. Andrade,et al.  Protein adsorption on low temperature isotropic carbon. III. Isotherms, competitivity, desorption and exchange of human albumin and fibrinogen. , 1994, Biomaterials.

[23]  Michel Vert,et al.  Biodistribution of Long-Circulating PEG-Grafted Nanocapsules in Mice: Effects of PEG Chain Length and Density , 2001, Pharmaceutical Research.

[24]  R. Gurny,et al.  An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. , 1995, Life sciences.

[25]  Peter Ramge,et al.  Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier , 2002, Journal of drug targeting.

[26]  D. Hochstrasser,et al.  Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting , 1996 .

[27]  R. Müller,et al.  Production of Biofunctionalized Solid Lipid Nanoparticles for Site-specific Drug Delivery , 2007 .

[28]  N G Anderson,et al.  High resolution two-dimensional electrophoresis of human plasma proteins. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Müller,et al.  Plasma protein adsorption patterns on emulsions for parenteral administration: Establishment of a protocol for two‐dimensional polyacrylamide electrophoresis , 1998, Electrophoresis.

[30]  J. Klose.  Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues , 1975, Humangenetik.

[31]  V. Kolb-Bachofen,et al.  Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. , 1993, Biochimica et biophysica acta.

[32]  P. O’Farrell.  High resolution two-dimensional electrophoresis of proteins. , 1975, The Journal of biological chemistry.

[33]  Nathan Kohler,et al.  Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. , 2002, Biomaterials.

[34]  J. Andrade,et al.  Protein adsorption on low-temperature isotropic carbon: I. Protein conformational change probed by differential scanning calorimetry. , 1994, Journal of biomedical materials research.

[35]  B. Paulke,et al.  Protein rejecting properties of PEG-grafted nanoparticles: influence of PEG-chain length and surface density evaluated by two-dimensional electrophoresis and bicinchoninic acid (BCA)-proteinassay. , 2006, Die Pharmazie.

[36]  J. Kreuter,et al.  Nanoparticulate systems for brain delivery of drugs. , 2001 .

[37]  R. Juliano.  Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres and emulsions , 1988 .

[38]  A. Curtis,et al.  Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture , 2004, Journal of materials science. Materials in medicine.

[39]  J. Brash,et al.  Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma. , 2001, Biochimica et biophysica acta.

[40]  L. Låstbom,et al.  Experimental and calculated parameters on particle phagocytosis by alveolar macrophages. , 2002, Journal of applied physiology.

[41]  J. San Román,et al.  Quantitative analysis of protein adsorption via atomic force microscopy and surface plasmon resonance. , 2008, Macromolecular bioscience.